Is this you? Create Your Porfile
Avatar

Maria Carmen Fernandez

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Maria Carmen Fernandez is active.

Explore More

Publication

Featured researches published by Maria Carmen Fernandez.

Archive | 2005

Compounds and methods for treating dyslipidemia

Xinchao Chen; Christopher L. Cioffi; Sean Richard Dinn; Ana Maria Escribano; Maria Carmen Fernandez; Todd Fields; Robert Jason Herr; Nathan Bryan Mantlo; De La Nava Eva Maria Martin; Ana Isabel Mateo-Herranz; Saravanan Parthasarathy; Xiaodong Wang

Archive | 2005

Thiophene and furan compounds

Ana Maria Castano Mansanet; Esteban Dominguez-Manzanares; Ana Maria Escribano; Maria Carmen Fernandez; William Joseph Hornback; Alma Maria Jimenez-Aguado; Eric George Tromiczak; Zhipei Wu; Hamideh Zarrinmayeh; Dennis M. Zimmerman

Archive | 2013

PHENYL METHANESULFONAMIDE DERIVATIVES USEFUL AS MGAT - 2 INHIBITORS

Maria Carmen Fernandez; Maria Rosario Gonzalez-Garcia; Bin Liu; Lance Allen Pfeifer

Archive | 2005

Compounds and method for treating dyslipidemia

Xinchao Chen; Christopher L. Cioffi; Sean Richard Dinn; Ana Maria Escribano; Maria Carmen Fernandez; Todd Fields; Robert Jason Herr; Nathan Bryan Mantlo; Eva Maria Martin De La Nava; Ana Isabel Mateo-Herranz; Saravanan Parthasarathy; Xiaodong Wang

Archive | 2013

NOVEL MORPHOLINYL DERIVATIVES USEFUL AS MOGAT-2 INHIBITORS

Maria Rosario Gonzalez-Garcia; Maria Carmen Fernandez

Archive | 2013

BENZYL SULFONAMIDE DERIVATIVES USEFUL AS MOGAT - 2 INHIBITORS

Maria Carmen Fernandez; Lance Allen Pfeifer; Maria Rosario Gonzalez-Garcia

Archive | 2004

Compounds and methods for treating dislipidemia

Guoqing Cao; Ana Maria Escribano; Maria Carmen Fernandez; Todd Fields; Douglas Linn Gernert; Christopher L. Cioffi; Robert Jason Herr; Nathan Bryan Mantlo; Eva Maria Martin De La Nava; Ana Isabel Mateo Herranz; Daniel Ray Mayhugh; Xiaodong Wang

Archive | 2015

NOVEL PYRIDYLOXYACETYL TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS NAMPT INHIBITORS

Timothy Paul Burkholder; Miriam del Prado; Maria Carmen Fernandez; Lawrence Joseph Heinz; Lourdes Prieto; Genshi Zhao

Archive | 2014

Nouveaux composés de pyridyloxyacétyl tétrahydroisoquinoline utiles en tant qu'inhibiteurs de nampt

Timothy Paul Burkholder; Prado Miriam Filadelfa Del; Maria Carmen Fernandez; Ii Lawrence Joseph Heinz; Lourdes Prieto; Genshi Zhao

Archive | 2013

Morpholinyl derivatives useful as MOGAT-2 inhibitors

Maria Rosario Gonzalez-Garcia; Maria Carmen Fernandez

Explore More

Collaboration

Dive into the Maria Carmen Fernandez's collaboration.

Top Co-Authors
Avatar

Nathan Bryan Mantlo

Merck

View shared research outputs
Top Co-Authors
Avatar

De La Nava Eva Maria Martin

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Ana Maria Escribano

Spanish National Research Council

View shared research outputs
Top Co-Authors
Avatar

Daniel Ray Mayhugh

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Guoqing Cao

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Christopher L. Cioffi

Columbia University

View shared research outputs
Top Co-Authors
Avatar

Robert Jason Herr

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Todd Fields

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Michael Gregory Bell

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Ana Isabel Mateo-Herranz

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge